img

Global Metabotropic Glutamate Receptor 5 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Metabotropic Glutamate Receptor 5 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Metabotropic Glutamate Receptor 5 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Metabotropic Glutamate Receptor 5 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Major Depressive Disorder and Alcohol Addiction are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Metabotropic Glutamate Receptor 5 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Metabotropic Glutamate Receptor 5 key manufacturers include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Eisai Co Ltd, Eli Lilly and Company, Heptares Therapeutics Ltd, Johnson & Johnson, Merz Pharma GmbH & Co KgaA and Novartis AG, etc. Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company are top 3 players and held % sales share in total in 2022.
Metabotropic Glutamate Receptor 5 can be divided into Alloswitch-1, BMS-952048, BMS-955829 and Dipraglurant ER, etc. Alloswitch-1 is the mainstream product in the market, accounting for % sales share globally in 2022.
Metabotropic Glutamate Receptor 5 is widely used in various fields, such as Major Depressive Disorder, Alcohol Addiction, Alzheimer's Disease and Others, etc. Major Depressive Disorder provides greatest supports to the Metabotropic Glutamate Receptor 5 industry development. In 2022, global % sales of Metabotropic Glutamate Receptor 5 went into Major Depressive Disorder filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Metabotropic Glutamate Receptor 5 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
Segment by Type
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others

Segment by Application


Major Depressive Disorder
Alcohol Addiction
Alzheimer's Disease
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Metabotropic Glutamate Receptor 5 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Metabotropic Glutamate Receptor 5, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Metabotropic Glutamate Receptor 5 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Metabotropic Glutamate Receptor 5 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Metabotropic Glutamate Receptor 5 introduction, etc. Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Metabotropic Glutamate Receptor 5 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Metabotropic Glutamate Receptor 5 Market Overview
1.1 Metabotropic Glutamate Receptor 5 Product Overview
1.2 Metabotropic Glutamate Receptor 5 Market Segment by Type
1.2.1 Alloswitch-1
1.2.2 BMS-952048
1.2.3 BMS-955829
1.2.4 Dipraglurant ER
1.2.5 Others
1.3 Global Metabotropic Glutamate Receptor 5 Market Size by Type
1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size Overview by Type (2018-2034)
1.3.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size Review by Type (2018-2024)
1.3.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2018-2024)
1.4.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2018-2024)
2 Global Metabotropic Glutamate Receptor 5 Market Competition by Company
2.1 Global Top Players by Metabotropic Glutamate Receptor 5 Sales (2018-2024)
2.2 Global Top Players by Metabotropic Glutamate Receptor 5 Revenue (2018-2024)
2.3 Global Top Players by Metabotropic Glutamate Receptor 5 Price (2018-2024)
2.4 Global Top Manufacturers Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Metabotropic Glutamate Receptor 5 Market Competitive Situation and Trends
2.5.1 Metabotropic Glutamate Receptor 5 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Metabotropic Glutamate Receptor 5 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2022)
2.7 Date of Key Manufacturers Enter into Metabotropic Glutamate Receptor 5 Market
2.8 Key Manufacturers Metabotropic Glutamate Receptor 5 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Metabotropic Glutamate Receptor 5 Status and Outlook by Region
3.1 Global Metabotropic Glutamate Receptor 5 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size by Region
3.2.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2018-2024)
3.2.2 Global Metabotropic Glutamate Receptor 5 Sales in Value by Region (2018-2024)
3.2.3 Global Metabotropic Glutamate Receptor 5 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Region
3.3.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2024-2034)
3.3.2 Global Metabotropic Glutamate Receptor 5 Sales in Value by Region (2024-2034)
3.3.3 Global Metabotropic Glutamate Receptor 5 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Metabotropic Glutamate Receptor 5 by Application
4.1 Metabotropic Glutamate Receptor 5 Market Segment by Application
4.1.1 Major Depressive Disorder
4.1.2 Alcohol Addiction
4.1.3 Alzheimer's Disease
4.1.4 Others
4.2 Global Metabotropic Glutamate Receptor 5 Market Size by Application
4.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Overview by Application (2018-2034)
4.2.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size Review by Application (2018-2024)
4.2.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2018-2024)
4.3.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2018-2024)
5 North America Metabotropic Glutamate Receptor 5 by Country
5.1 North America Metabotropic Glutamate Receptor 5 Historic Market Size by Country
5.1.1 North America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2018-2024)
5.1.3 North America Metabotropic Glutamate Receptor 5 Sales in Value by Country (2018-2024)
5.2 North America Metabotropic Glutamate Receptor 5 Forecasted Market Size by Country
5.2.1 North America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2024-2034)
5.2.2 North America Metabotropic Glutamate Receptor 5 Sales in Value by Country (2024-2034)
6 Europe Metabotropic Glutamate Receptor 5 by Country
6.1 Europe Metabotropic Glutamate Receptor 5 Historic Market Size by Country
6.1.1 Europe Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2018-2024)
6.1.3 Europe Metabotropic Glutamate Receptor 5 Sales in Value by Country (2018-2024)
6.2 Europe Metabotropic Glutamate Receptor 5 Forecasted Market Size by Country
6.2.1 Europe Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2024-2034)
6.2.2 Europe Metabotropic Glutamate Receptor 5 Sales in Value by Country (2024-2034)
7 Asia-Pacific Metabotropic Glutamate Receptor 5 by Region
7.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Historic Market Size by Region
7.1.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Forecasted Market Size by Region
7.2.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales in Value by Region (2024-2034)
8 Latin America Metabotropic Glutamate Receptor 5 by Country
8.1 Latin America Metabotropic Glutamate Receptor 5 Historic Market Size by Country
8.1.1 Latin America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2018-2024)
8.1.3 Latin America Metabotropic Glutamate Receptor 5 Sales in Value by Country (2018-2024)
8.2 Latin America Metabotropic Glutamate Receptor 5 Forecasted Market Size by Country
8.2.1 Latin America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2024-2034)
8.2.2 Latin America Metabotropic Glutamate Receptor 5 Sales in Value by Country (2024-2034)
9 Middle East and Africa Metabotropic Glutamate Receptor 5 by Country
9.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Historic Market Size by Country
9.1.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Forecasted Market Size by Country
9.2.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Addex Therapeutics Ltd
10.1.1 Addex Therapeutics Ltd Company Information
10.1.2 Addex Therapeutics Ltd Introduction and Business Overview
10.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
10.1.5 Addex Therapeutics Ltd Recent Development
10.2 Aevi Genomic Medicine Inc
10.2.1 Aevi Genomic Medicine Inc Company Information
10.2.2 Aevi Genomic Medicine Inc Introduction and Business Overview
10.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Products Offered
10.2.5 Aevi Genomic Medicine Inc Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Information
10.3.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Products Offered
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 Eisai Co Ltd
10.4.1 Eisai Co Ltd Company Information
10.4.2 Eisai Co Ltd Introduction and Business Overview
10.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Products Offered
10.4.5 Eisai Co Ltd Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Heptares Therapeutics Ltd
10.6.1 Heptares Therapeutics Ltd Company Information
10.6.2 Heptares Therapeutics Ltd Introduction and Business Overview
10.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
10.6.5 Heptares Therapeutics Ltd Recent Development
10.7 Johnson & Johnson
10.7.1 Johnson & Johnson Company Information
10.7.2 Johnson & Johnson Introduction and Business Overview
10.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Products Offered
10.7.5 Johnson & Johnson Recent Development
10.8 Merz Pharma GmbH & Co KgaA
10.8.1 Merz Pharma GmbH & Co KgaA Company Information
10.8.2 Merz Pharma GmbH & Co KgaA Introduction and Business Overview
10.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Products Offered
10.8.5 Merz Pharma GmbH & Co KgaA Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Information
10.9.2 Novartis AG Introduction and Business Overview
10.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Products Offered
10.9.5 Novartis AG Recent Development
10.10 Richter Gedeon Nyrt
10.10.1 Richter Gedeon Nyrt Company Information
10.10.2 Richter Gedeon Nyrt Introduction and Business Overview
10.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Products Offered
10.10.5 Richter Gedeon Nyrt Recent Development
10.11 Sumitomo Dainippon Pharma Co Ltd
10.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information
10.11.2 Sumitomo Dainippon Pharma Co Ltd Introduction and Business Overview
10.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Products Offered
10.11.5 Sumitomo Dainippon Pharma Co Ltd Recent Development
10.12 Toray Industries Inc
10.12.1 Toray Industries Inc Company Information
10.12.2 Toray Industries Inc Introduction and Business Overview
10.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Products Offered
10.12.5 Toray Industries Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Metabotropic Glutamate Receptor 5 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis
11.4 Metabotropic Glutamate Receptor 5 Market Dynamics
11.4.1 Metabotropic Glutamate Receptor 5 Industry Trends
11.4.2 Metabotropic Glutamate Receptor 5 Market Drivers
11.4.3 Metabotropic Glutamate Receptor 5 Market Challenges
11.4.4 Metabotropic Glutamate Receptor 5 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Metabotropic Glutamate Receptor 5 Distributors
12.3 Metabotropic Glutamate Receptor 5 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Alloswitch-1
Table 2. Major Company of BMS-952048
Table 3. Major Company of BMS-955829
Table 4. Major Company of Dipraglurant ER
Table 5. Major Company of Others
Table 6. Global Metabotropic Glutamate Receptor 5 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US& Million)
Table 10. Global Metabotropic Glutamate Receptor 5 Market Share in Value by Type (2018-2024)
Table 11. Global Metabotropic Glutamate Receptor 5 Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Metabotropic Glutamate Receptor 5 Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Metabotropic Glutamate Receptor 5 Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type (2024-2034)
Table 16. Global Metabotropic Glutamate Receptor 5 Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Metabotropic Glutamate Receptor 5 Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Metabotropic Glutamate Receptor 5 Sales Share by Company (2018-2024)
Table 29. Global Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Metabotropic Glutamate Receptor 5 Revenue Share by Company (2018-2024)
Table 31. Global Market Metabotropic Glutamate Receptor 5 Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Metabotropic Glutamate Receptor 5 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Metabotropic Glutamate Receptor 5 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2022)
Table 35. Date of Key Manufacturers Enter into Metabotropic Glutamate Receptor 5 Market
Table 36. Key Manufacturers Metabotropic Glutamate Receptor 5 Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Metabotropic Glutamate Receptor 5 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Metabotropic Glutamate Receptor 5 Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Metabotropic Glutamate Receptor 5 Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2018-2024)
Table 43. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Metabotropic Glutamate Receptor 5 Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Metabotropic Glutamate Receptor 5 Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2024-2034)
Table 48. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Metabotropic Glutamate Receptor 5 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application (2018-2024)
Table 54. Global Metabotropic Glutamate Receptor 5 Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Metabotropic Glutamate Receptor 5 Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Metabotropic Glutamate Receptor 5 Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application (2024-2034)
Table 59. Global Metabotropic Glutamate Receptor 5 Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) (K Pcs)
Table 61. North America Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2018-2024)
Table 74. North America Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Country (2024-2034)
Table 110. Addex Therapeutics Ltd Company Information
Table 111. Addex Therapeutics Ltd Introduction and Business Overview
Table 112. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product
Table 114. Addex Therapeutics Ltd Recent Development
Table 115. Aevi Genomic Medicine Inc Company Information
Table 116. Aevi Genomic Medicine Inc Introduction and Business Overview
Table 117. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product
Table 119. Aevi Genomic Medicine Inc Recent Development
Table 120. Bristol-Myers Squibb Company Company Information
Table 121. Bristol-Myers Squibb Company Introduction and Business Overview
Table 122. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product
Table 124. Bristol-Myers Squibb Company Recent Development
Table 125. Eisai Co Ltd Company Information
Table 126. Eisai Co Ltd Introduction and Business Overview
Table 127. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product
Table 129. Eisai Co Ltd Recent Development
Table 130. Eli Lilly and Company Company Information
Table 131. Eli Lilly and Company Introduction and Business Overview
Table 132. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product
Table 134. Eli Lilly and Company Recent Development
Table 135. Heptares Therapeutics Ltd Company Information
Table 136. Heptares Therapeutics Ltd Introduction and Business Overview
Table 137. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product
Table 139. Heptares Therapeutics Ltd Recent Development
Table 140. Johnson & Johnson Company Information
Table 141. Johnson & Johnson Introduction and Business Overview
Table 142. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product
Table 144. Johnson & Johnson Recent Development
Table 145. Merz Pharma GmbH & Co KgaA Company Information
Table 146. Merz Pharma GmbH & Co KgaA Introduction and Business Overview
Table 147. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product
Table 149. Merz Pharma GmbH & Co KgaA Recent Development
Table 150. Novartis AG Company Information
Table 151. Novartis AG Introduction and Business Overview
Table 152. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Novartis AG Metabotropic Glutamate Receptor 5 Product
Table 154. Novartis AG Recent Development
Table 155. Richter Gedeon Nyrt Company Information
Table 156. Richter Gedeon Nyrt Introduction and Business Overview
Table 157. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product
Table 159. Richter Gedeon Nyrt Recent Development
Table 160. Sumitomo Dainippon Pharma Co Ltd Company Information
Table 161. Sumitomo Dainippon Pharma Co Ltd Introduction and Business Overview
Table 162. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product
Table 164. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 165. Toray Industries Inc Company Information
Table 166. Toray Industries Inc Introduction and Business Overview
Table 167. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product
Table 169. Toray Industries Inc Recent Development
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Metabotropic Glutamate Receptor 5 Market Trends
Table 173. Metabotropic Glutamate Receptor 5 Market Drivers
Table 174. Metabotropic Glutamate Receptor 5 Market Challenges
Table 175. Metabotropic Glutamate Receptor 5 Market Restraints
Table 176. Metabotropic Glutamate Receptor 5 Distributors List
Table 177. Metabotropic Glutamate Receptor 5 Downstream Customers
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 5 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 5 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Metabotropic Glutamate Receptor 5 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Metabotropic Glutamate Receptor 5 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Alloswitch-1
Figure 6. Global Alloswitch-1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of BMS-952048
Figure 8. Global BMS-952048 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of BMS-955829
Figure 10. Global BMS-955829 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Dipraglurant ER
Figure 12. Global Dipraglurant ER Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Metabotropic Glutamate Receptor 5 Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2022 & 2034
Figure 17. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2022
Figure 18. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2022
Figure 19. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2022
Figure 20. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2022
Figure 23. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Metabotropic Glutamate Receptor 5 Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Metabotropic Glutamate Receptor 5 Revenue in 2022
Figure 29. Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Major Depressive Disorder
Figure 31. Global Major Depressive Disorder Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Alcohol Addiction
Figure 33. Global Alcohol Addiction Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Alzheimer's Disease
Figure 35. Global Alzheimer's Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Metabotropic Glutamate Receptor 5 Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2022 & 2034
Figure 40. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2022
Figure 41. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2022
Figure 42. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2022
Figure 43. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2022
Figure 46. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Metabotropic Glutamate Receptor 5 Manufacturing Cost Structure
Figure 51. Metabotropic Glutamate Receptor 5 Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries